Mélanie Claps

机构：Fondazione IRCCS Istituto Nazionale dei Tumori · ORCID：0000-0001-7932-7898

发表论文 120 篇 · 总被引 1207 次 · h-index 19

代表论文

• Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors (2024 · JAMA Network Open · 被引 48)
• Characterization of complete responders to nivolumab + gemcitabine-cisplatin vs gemcitabine-cisplatin alone and patients with lymph node–only metastatic urothelial carcinoma from the CheckMate 901 trial. (2024 · Journal of Clinical Oncology · 被引 14)
• Characterization of Patients with Lymph Node Only Metastatic Urothelial Carcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin Alone from the CheckMate 901 Trial (2025 · European Urology · 被引 10)
• Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study (2024 · Frontiers in Immunology · 被引 9)
• A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study) (2024 · Therapeutic Advances in Medical Oncology · 被引 6)
• mRNA-Based Urine Test Performance in High and Very-High Risk Non–Muscle-Invasive Bladder Cancer Patients Undergoing Contextual Endoscopic Follow-up (VERNAL: Vesical Tumor Early Monitoring: mRNA-Based Follow-up) (2025 · Clinical Genitourinary Cancer · 被引 4)